- Home
- KLTOW vs LPTH Comparison
KLTOW vs LPTH Comparison
Compare KLTOW & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTOW
- LPTH
- Stock Information
- Founded
- KLTOW N/A
- LPTH 1985
- Country
- KLTOW United States
- LPTH United States
- Employees
- KLTOW 3
- LPTH N/A
- Industry
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- LPTH Semiconductors
- Sector
- KLTOW Health Care
- LPTH Technology
- Exchange
- KLTOW Nasdaq
- LPTH Nasdaq
- Market Cap
- KLTOW N/A
- LPTH 377.5M
- IPO Year
- KLTOW 2022
- LPTH 1996
- Fundamental
- Price
- KLTOW $0.17
- LPTH $8.16
- Analyst Decision
- KLTOW
- LPTH Strong Buy
- Analyst Count
- KLTOW 0
- LPTH 3
- Target Price
- KLTOW N/A
- LPTH $6.83
- AVG Volume (30 Days)
- KLTOW N/A
- LPTH 2.2M
- Earning Date
- KLTOW N/A
- LPTH 11-13-2025
- Dividend Yield
- KLTOW N/A
- LPTH N/A
- EPS Growth
- KLTOW N/A
- LPTH N/A
- EPS
- KLTOW N/A
- LPTH N/A
- Revenue
- KLTOW N/A
- LPTH $37,202,630.00
- Revenue This Year
- KLTOW N/A
- LPTH $62.13
- Revenue Next Year
- KLTOW N/A
- LPTH $22.15
- P/E Ratio
- KLTOW N/A
- LPTH N/A
- Revenue Growth
- KLTOW N/A
- LPTH 17.26
- 52 Week Low
- KLTOW N/A
- LPTH $1.40
- 52 Week High
- KLTOW N/A
- LPTH $10.69
- Technical
- Relative Strength Index (RSI)
- KLTOW 50.51
- LPTH 51.29
- Support Level
- KLTOW $0.15
- LPTH $7.84
- Resistance Level
- KLTOW $0.17
- LPTH $9.03
- Average True Range (ATR)
- KLTOW 0.02
- LPTH 0.86
- MACD
- KLTOW -0.00
- LPTH -0.12
- Stochastic Oscillator
- KLTOW 42.70
- LPTH 32.21
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.